Where I see patients (1)
My reviews

"There is value in the hope of achieving more than we expect."
Selected research
-
Plain language summary of the HIMALAYA study: tremelimumab and durvalumab for unresectable hepatocellular carcinoma (liver cancer).
Future oncology (London, England)
-
Immune Checkpoint Inhibitors for Child-Pugh Class B Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
JAMA oncology
-
Modeling of Proliferating CD4 and CD8 T-Cell Changes to Tremelimumab Exposure in Patients with Unresectable Hepatocellular Carcinoma.
Clinical pharmacology and therapeutics
Clinical trials
My work
Contact me
- Request appointment
- Refer a patient
- (415) 353-9888
4.9